| Date | Subject |
| 12/22/2011 02:52:19 PM | |
| Prophylactic Nevirapine to Prevent Mother-to-Child HIV Transmission Can Be Safely Extended |
| 12/21/2011 06:39:40 PM | |
| FDA Expands Use of Raltegravir to Children and Adolescents With HIV |
| 12/14/2011 05:29:11 PM | |
| HPV Testing Best Cervical Screening Option for All Women Over the Age of 30 |
| 12/01/2011 05:39:32 PM | |
| CD4+ Testing as Effective as Viral Load Testing for HIV Treatment Monitoring |
| 10/06/2011 04:59:37 PM | |
| FDA Approves Tadalafil to Treat Benign Prostatic Hyperplasia |
| 09/28/2011 05:09:14 PM | |
| Oral Tenofovir Ineffective for Preventing HIV Transmission in Women |
| 09/25/2011 06:33:25 PM | |
| Bivalent HPV Vaccine Demonstrates Protection Up to 9.4 Years in Young Women: Presented at IPC |
| 09/25/2011 06:27:05 PM | |
| HPV Vaccine Decreases Recurrence of High-Grade Anal Intraepithelial Neoplasia in Men: Presented at IPC |
| 09/21/2011 08:22:37 PM | |
| Switching to Emtricitabine/Tenofovir HIV Regimen Can Improve Lipids, Reduce Risk of Virologic Failure: Presented at ICAAC |
| 08/03/2011 05:11:42 PM | |
| US Data Show Alarming Increase in New HIV Infections Among Young, Black Gay Men |
| 07/23/2011 06:53:58 AM | |
| Analysis Shows Infant Nevirapine Prophylaxis May Prevent Breast Milk HIV Transmission: Presented at IAS |
| 07/23/2011 06:43:50 AM | |
| Preventing HIV-1 Transmission With Early Antiretroviral Therapy: Presented at IAS |
| 07/23/2011 06:20:54 AM | |
| Investigational Once-Daily Elvitegravir Appears Noninferior to Twice-Daily Raltegravir: Presented at IAS |
| 07/22/2011 06:40:18 AM | |
| Resistant HIV Observed in Young Adults First Presenting With Infection: Presented at IAS |
| 07/22/2011 06:35:15 AM | |
| Researchers Call for Further Study of Tenofovir-Containing Regimen for Initial HIV Therapy: Presented at IAS |
| 07/20/2011 05:12:57 PM | |
| Study IDs Predictors of Mortality Among Patients Initiating Antiretroviral Therapy in India: Presented at IAS |
| 07/12/2011 05:14:52 PM | |
| CDC Report Shows Antibiotic-Resistant Gonorrhoea is a Possibility |
| 06/16/2011 04:38:18 PM | |
| High-Grade Cervical Abnormalities Have Decreased Following Intro of HPV Vaccine |
| 06/15/2011 07:32:46 PM | |
| Increasing Prenatal Syphilis Screening, Treatment Could Halve Stillbirths and Newborn Deaths |
| 06/07/2011 12:11:07 PM | |
| Human Papillomavirus and Papanicolaou Co-Testing in Routine Clinical Practice Can Safely Extend Screening to Every 3 Years: Presented at ASCO |
| 04/11/2011 06:38:13 PM | |
| Dual-Therapy Antiretroviral Therapy Maintains Viral Suppression: Presented at BHIVA |
| 04/11/2011 06:33:39 PM | |
| Concomitant Medications Should Be Monitored in Patients With HIV on Antiretroviral Therapy: Presented at BHIVA |
| 04/10/2011 04:00:32 PM | |
| Once-Daily Emtricitabine/Tenofovir/Efavirenz Tablet Maintains Viral Suppression in HIV+ Patients at 48 Weeks: Presented at BHIVA |
| 04/10/2011 02:40:30 PM | |
| Presence of Atazanavir-Related Hyperbilirubinaemia Does Not Affect HIV Clinical Outcome: Presented at BHIVA |
| 04/10/2011 01:57:34 PM | |
| No Increased Cardiovascular Risk Seen With Abacavir-Based Treatment in Patients With HIV: Presented at BHIVA |
| 04/10/2011 01:48:06 PM | |
| Continuous Tenofovir-Based HAART Controls HIV Disease Symptoms at 10 Years: Presented at BHIVA |
| 03/14/2011 08:08:56 PM | |
| Tumour Suppressor Blocks Viral Growth in Natural HIV Controllers |
| 01/31/2011 11:48:44 AM | |
| FDA Approves Once-Daily Gabapentin for Post-Herpetic Neuralgia |
| 11/22/2010 05:31:35 PM | |
| ACOG Publishes Guidelines on Gynecologic Care for Women With HIV |
| 11/18/2010 05:20:43 PM | |
| White Blood Cell Count a Useful Cardiac-Event Predictor in Patients With HIV: Presented at AHA |
| 10/30/2010 05:31:08 PM | |
| Men Can Be Successfully Screened for STDs in the Emergency Room: Presented at ASCP |
| 10/30/2010 05:10:23 PM | |
| Chlamydia trachomatis Screening May Indicate Laparoscopic Tubal Repair or In Vitro Fertilisation: Presented at ASRM |
| 10/25/2010 07:16:01 PM | |
| Safety Findings for TMC278, Efavirenz Are Similar Across Both Race and Gender: Presented at IDSA |
| 09/20/2010 12:47:19 PM | |
| PRO2000 Vaginal Gel Does Not Protect African Women From HIV Infection |
| 09/16/2010 04:47:02 PM | |
| Topical Acyclovir/Hydrocortisone Does Not Increase Risk of Phototoxicity in Patients Treated for Herpes: Presented at ICAAC |
| 09/16/2010 12:37:49 PM | |
| Switching Antiretroviral Regimens Can Benefit Patients' Lipid Profiles: Presented at ICAAC |
| 09/16/2010 12:21:04 PM | |
| Raltegravir Pharmacokinetics Disrupted by Antacids in Healthy Patients With HIV: Presented at ICAAC |
| 09/15/2010 02:31:41 PM | |
| Vicriviroc Reduces HIV Viral Load But Falls Short in Efficacy Among Treatment-Naïve Patients: Presented at ICAAC |
| 09/15/2010 01:31:35 PM | |
| Investigative 4-Drug Combination Tablet for HIV Non-Inferior to Standard 3-Drug Combo: Presented at ICAAC |
| 09/13/2010 11:38:19 AM | |
| Investigative Tesamorelin Reduces HIV-Associated Visceral Fat in Multiple Sub-Populations: Presented at ICAAC |
| 09/07/2010 05:11:56 PM | |
| Nevirapine Switch May Benefit Some Children With HIV Who Have Achieved Viral Suppression |
| 07/13/2010 06:13:16 PM | |
| Quadrivalent HPV Vaccine Can Prevent Anal Intraepithelial Neoplasia in Men Who Have Sex With Men: Presented at IPC |
| 04/26/2010 06:43:29 PM | |
| Switching to Darunavir/Ritonavir Reverses Severe Vitamin D Deficiency in HIV Patients: Presented at BHIVA |
| 04/24/2010 09:02:30 PM | |
| Early HAART in Pregnancy Improves Chances of Undetectable Viral Load at Delivery: Presented at BHIVA |
| 04/24/2010 05:44:09 PM | |
| Early Viral Suppression Has No Impact on Long-Term Viral Rebound Rate: Presented at BHIVA |
| 04/24/2010 02:41:41 PM | |
| Despite Toxicity, Long-Term Thymidine Use Can Benefit Patients With HIV: Presented at BHIVA |
| 04/24/2010 02:37:35 PM | |
| Three Drugs Unnecessary in HIV Patients With M184 Mutation: Presented at BHIVA |
| 03/02/2010 05:42:23 PM | |
| Nevirapine Can Be Resumed 1 Year After Childbirth in Mothers With HIV |
| 01/12/2010 05:42:29 PM | |
| Switching HIV-Infected Patients to Raltegravir Improves Lipids, But With Lower Virological Control |
| 01/07/2010 07:08:11 PM | |
| Study Finds Increased Presence, Severity of Coronary Artery Plaques in HIV-Positive Men |
| 11/20/2009 09:16:50 AM | |
| ACOG Recommends Pap Tests Begin Later, Be Repeated Less Frequently |
| 11/01/2009 11:19:42 AM | |
| New Vaccine for Human Papillomavirus 16/18 Shows High Levels of Immunogenicity: Presented at IDSA |
| 10/20/2009 05:21:23 PM | |
| Combination HIV Vaccine Regimen Demonstrates Modest Efficacy |
| 09/09/2009 06:33:47 PM | |
| Trichomonas Vaginalis Linked to Increased Risk of Aggressive Prostate Cancer |
| 08/31/2009 04:11:22 PM | |
| HIV Subtype D Linked to Increased Likelihood for Dementia |
| 08/17/2009 11:55:02 AM | |
| Updated HIV Guidelines Emphasise Primary Care Need of Patients |
| 07/24/2009 05:24:01 PM | |
| Study Identifies Distinct Characteristics of Patients Presenting With Late Stage HIV: Presented at IAS |
| 07/23/2009 06:18:57 PM | |
| Once-Daily Darunavir/Ritonavir Monotherapy as Effective as Standard HAART: Presented at IAS |
| 07/23/2009 06:13:51 PM | |
| Simplified HIV Regimen Without Ritonavir Effective in HIV Patients With Suppressed Viral Loads: Presented at IAS |
| 07/23/2009 06:12:08 PM | |
| No Link Found Between Abacavir and Cardiovascular Disease Biomarkers: Presented at IAS |
| 07/23/2009 05:50:34 PM | |
| Abacavir Does Not Appear to Increase MI, Stroke Risk in Most HIV-Positive Patients: Presented at IAS |
| 07/23/2009 05:22:18 PM | |
| Once-Daily Lopinavir/Ritonavir as Effective as Twice Daily Dosing in Treatment-Experienced HIV Patients: Presented at IAS |
| 07/22/2009 06:21:36 PM | |
| Once-Daily Lopinavir/Ritonavir Tablets Show Similar, Durable Efficacy as Twice-Daily Dosing: Presented at IAS |
| 07/21/2009 04:04:31 PM | |
| Most Patients With NNRTI Resistance Maintain Susceptibility to Etravirine: Presented at IAS |
| 07/20/2009 06:21:05 PM | |
| Raltegravir Maintains Efficacy Versus Efavirenz After 144 Weeks: Presented at IAS |
| 07/20/2009 05:47:06 PM | |
| Nevirapine Equally Effective, Improves Lipids Compared With Atazanavir in HIV: Presented at IAS |
| 07/20/2009 05:32:33 PM | |
| Etravirine Offers Durable Virologic Efficacy in Patients Resistant to NNRTIs and PIs: Presented at IAS |
| 06/22/2009 05:49:06 PM | |
| Use of Assay Can Detect Lower Genital Tract Infections in Patients With Neisseria gonorrhoeae: Presented at ICC |
| 06/01/2009 01:49:55 PM | |
| HPV Vaccine Effective in Women Aged 24 to 45 Years Not Already Infected With the Virus |
| 05/31/2009 08:50:47 PM | |
| Tumour HPV Status Predicts Survival in Patients With Oropharynx Cancers: Presented at ASCO |
| 05/16/2009 02:30:57 PM | |
| Smoking Is Independent Risk Factor for Cervical Cancer in Women With Oncogenic HPV Types: Presented at IPV |
| 05/15/2009 06:20:44 PM | |
| Two-Dose Paediatric Regimen of Quadrivalent HPV Vaccine for Preadolescent Girls as Effective as 3 Doses: Presented at IPV |
| 05/15/2009 05:49:54 PM | |
| Quadrivalent HPV Vaccine Reduces Persistent Anogenital HPV Infection in Men Who Have Sex With Men: Presented at IPV |
| 05/15/2009 05:33:25 PM | |
| Bivalent HPV Vaccine Shows Efficacy Against Cervical Intraepithelial Neoplasia: Presented at IPV |
| 05/15/2009 05:24:13 PM | |
| Immunogenicity of Quadrivalent HPV Vaccine in Men Comparable to That of Women: Presented at IPV |
| 12/03/2008 01:30:35 PM | |
| European Union Approves Darunavir for Treatment-Experienced Patients |
| 11/14/2008 12:19:36 PM | |
| Percutaneous Coronary Intervention Safe in Patients Infected With HIV: Presented at AHA |
| 11/01/2008 12:47:02 PM | |
| Herpes Often Spread Unknowingly by Young Women: Presented at ICAAC/ISDA |
| 10/30/2008 10:58:27 AM | |
| Long-Term Results With Vicriviroc Show Decreasing Evidence of Malignancy: Presented at ICAAC/IDSA |
| 10/30/2008 09:35:41 AM | |
| Atazanavir/Ritonavir Noninferior to Lopinavir/Ritonavir Over 96 Weeks in Treatment-Naïve HIV Patients: Presented at ICAAC/IDSA |
| 10/28/2008 02:49:30 PM | |
| Darunavir/Ritonavir Achieves Superiority Over Lopinavir/Ritonavir in Suppressing Human Immunodeficiency Virus: Presented at ICAAC/IDSA |
| 10/14/2008 02:54:43 PM | |
| Efavirenz-Based Therapies Associated With Better Outcomes in HIV Patients in Developing Countries |
| 08/10/2008 08:23:25 PM | |
| HIV Patients Resistant to Non-Nucleoside Reverse Transcriptase Inhibitors Experience Superior Results With Etravirine: Presented at AIDS 2008 |
| 08/10/2008 08:18:47 PM | |
| Outcome Data Disputed in Abacavir/Lamivudine Comparison Trial: Presented at AIDS 2008 |
| 08/09/2008 08:06:48 AM | |
| HIV Patients With High Viral Load Worsen on Fixed-Dose Abacavir/Lamivudine Compared With Fixed-Dose Tenofovir/Emtricitabine: Presented at AIDS 2008 |
| 08/08/2008 07:02:26 PM | |
| Combination of 3 New HIV Drugs Drives Virus to Undetectable Levels in Treatment-Experienced Patients: Presented at AIDS 2008 |
| 08/08/2008 05:28:28 PM | |
| Abacavir Linked to Heart Disease in Patients With HIV: Presented at AIDS 2008 |
| 07/24/2008 03:07:16 PM | |
| Contaminated Nelfinavir Does Not Increase Cancer Risk, EMEA Concludes |
| 07/24/2008 10:22:31 AM | |
| Extended-Dose Nevirapine May Reduce Risk of Mother-to-Infant HIV Transmission in Developing Countries |
| 07/22/2008 05:05:21 PM | |
| New Noninvasive Methods Identified for Detecting Human Papillomavirus: Presented at AHNS |
| 07/22/2008 12:11:13 PM | |
| Presence of Human Papillomavirus Infection Has No Prognostic Value in Tongue Cancer Patients: Presented at AHNS |
| 07/18/2008 02:35:20 PM | |
| HIV Conquers Immune System Faster Than Previously Realised |
| 06/20/2008 08:52:43 AM | |
| Aciclovir Does Not Reduce HIV Acquisition in Women or Gay Men With Genital Herpes |
| 04/24/2008 10:26:27 AM | |
| Seven-Day Doxycycline Superior to Single-Dose Azithromycin in Men With C Trachomatis Urethritis: Presented at ECCMID |
| 03/27/2008 04:18:01 PM | |
| US FDA Issues Update of Ongoing HIV Drug Safety Review |
| 02/11/2008 09:12:42 AM | |
| Delay in Treatment Modification After Non-Protease Inhibitor Therapy Failure Increases Risk of HIV Progression: Presented at CROI |
| 02/11/2008 09:07:22 AM | |
| Higher Risk of Death for Treatment-Naive HIV Patients With High CD4-Positive Cell Counts: Presented at CROI |
| 02/08/2008 04:00:25 PM | |
| Growth Hormone Replacement Reduces Obesity and Improves Diastolic Blood Pressure in Patients With HIV: Presented at CROI |
| 02/08/2008 12:30:10 PM | |
| Boosted Interferon Achieves Sustained Virologic Response With Reduced Liver Complications in Patients With HIV/Hepatitis C: Presented at CROI |
| 02/07/2008 03:13:48 PM | |
| IL-2 Fails to Boost CD4 Cells, But T-20 Proves Effective in Severely Immunocompromised HIV Patients: Presented at CROI |
| 02/07/2008 02:31:52 PM | |
